Zacks Investment Research lowered shares of Omega Healthcare Investors (NYSE:OHI) from a hold rating to a sell rating in a research report report published on Tuesday morning.
According to Zacks, “Omega Healthcare Investors, Inc. was incorporated in the State of Maryland. It is a self-administered real estate investment trust (REIT), investing in income producing healthcare facilities, principally long-term care facilities located in the United States (U.S.) and the United Kingdom (U.K.). The Company provide lease or mortgage financing to qualified operators of skilled nursing facilities (SNFs) and, to a lesser extent, assisted living facilities (ALFs), independent living facilities and rehabilitation and acute care facilities. It has historically financed investments through borrowings under its revolving credit facilities, private placements or public offerings of its debt and equity securities, the assumption of secured indebtedness, retention of cash flow, or a combination of these methods. “
A number of other brokerages have also recently weighed in on OHI. SunTrust Banks restated a hold rating and set a $30.00 price objective on shares of Omega Healthcare Investors in a research note on Wednesday, November 1st. ValuEngine cut Omega Healthcare Investors from a buy rating to a hold rating in a research note on Friday, February 2nd. Cantor Fitzgerald initiated coverage on Omega Healthcare Investors in a research note on Wednesday, December 20th. They set an overweight rating and a $34.00 price objective for the company. Stifel Nicolaus restated a hold rating and set a $27.00 price objective (down from $29.00) on shares of Omega Healthcare Investors in a research note on Wednesday, February 14th. Finally, Jefferies Group restated an underperform rating on shares of Omega Healthcare Investors in a research note on Thursday, December 21st. Three analysts have rated the stock with a sell rating, five have issued a hold rating and three have issued a buy rating to the company. The company currently has an average rating of Hold and an average price target of $31.37.
Shares of Omega Healthcare Investors (OHI) opened at $26.45 on Tuesday. Omega Healthcare Investors has a 1-year low of $24.90 and a 1-year high of $35.14. The firm has a market capitalization of $5,220.00, a price-to-earnings ratio of 57.50, a price-to-earnings-growth ratio of 3.02 and a beta of 0.41. The company has a debt-to-equity ratio of 1.18, a current ratio of 3.55 and a quick ratio of 3.40.
Omega Healthcare Investors (NYSE:OHI) last issued its earnings results on Tuesday, February 13th. The real estate investment trust reported $0.31 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.49 by ($0.18). The firm had revenue of $221.21 million during the quarter, compared to analysts’ expectations of $219.07 million. Omega Healthcare Investors had a return on equity of 2.48% and a net margin of 11.06%. sell-side analysts predict that Omega Healthcare Investors will post 2.95 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Thursday, February 15th. Shareholders of record on Wednesday, January 31st were paid a $0.66 dividend. The ex-dividend date was Tuesday, January 30th. This is a boost from Omega Healthcare Investors’s previous quarterly dividend of $0.65. This represents a $2.64 dividend on an annualized basis and a yield of 9.98%. Omega Healthcare Investors’s dividend payout ratio (DPR) is 573.91%.
In other Omega Healthcare Investors news, Director Bernard J. Korman purchased 100,000 shares of the firm’s stock in a transaction on Friday, December 22nd. The stock was bought at an average cost of $26.89 per share, for a total transaction of $2,689,000.00. Following the completion of the purchase, the director now owns 896,895 shares in the company, valued at approximately $24,117,506.55. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.54% of the company’s stock.
Institutional investors have recently added to or reduced their stakes in the business. Barnett & Company Inc. raised its stake in Omega Healthcare Investors by 1,980.0% in the third quarter. Barnett & Company Inc. now owns 5,200 shares of the real estate investment trust’s stock valued at $166,000 after buying an additional 4,950 shares during the last quarter. Mcmillion Capital Management Inc. purchased a new stake in Omega Healthcare Investors in the third quarter valued at about $201,000. Timber Hill LLC purchased a new stake in Omega Healthcare Investors in the third quarter valued at about $206,000. Good Life Advisors LLC purchased a new stake in Omega Healthcare Investors in the third quarter valued at about $209,000. Finally, Lourd Capital LLC purchased a new stake in Omega Healthcare Investors in the fourth quarter valued at about $202,000. Institutional investors own 71.90% of the company’s stock.
TRADEMARK VIOLATION NOTICE: “Zacks Investment Research Downgrades Omega Healthcare Investors (OHI) to Sell” was reported by Stock Observer and is the sole property of of Stock Observer. If you are viewing this news story on another website, it was stolen and reposted in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.thestockobserver.com/2018/02/21/zacks-investment-research-downgrades-omega-healthcare-investors-ohi-to-sell.html.
About Omega Healthcare Investors
Omega Healthcare Investors, Inc is a self-administered real estate investment trust (REIT). The Company maintains a portfolio of long-term healthcare facilities and mortgages on healthcare facilities located in the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.